Latest news
22.10.2017
AGAH Discussion Forum November 8, 2017
Dr. Plassmann will contribute to this discussion forum about the practical implementation of the revised „Guideline on strategies to identify and mitigate risks for first-in-human clinical trials with investigational medicinal products (EMEA/CHMP/SWP/28367/07 Revision 1)“